Simulation is a valuable tool used to educate and train health professionals. Where simulation involves models that are intended to replicate clinical or technical tasks, there are gaps in our...

29

Jan

Simulator realism establishes scenario that learners embrace

Mater congratulates the four Mater People recognised in this year’s Australia Day Honours list.

29

Jan

Mater People recognised in Australia Day Honours

Professor Vicki Flenady and her team at the Stillbirth Centre of Research Excellence (CRE) at Mater Research Institute – University of Queensland were awarded the UQ Faculty of Medicine...

24

Jan

Mater researchers recognised for their extensive collaborations

Join the Miles for Miracles: Japan Trek 2019 and help give the best possible start to life for all babies born and cared for at Mater.

18

Jan

Join the Miles for Miracles trek—Japan 2019

Dr Peter Steer has commenced his appointment as Mater Group Chief Executive Officer.

09

Jan

New Mater Group CEO takes the reins

The 2017/2018 Mater Annual Review is now available online.

20

Dec

Mater's 2017/2018 Annual Review

Researchers from Mater Research have been awarded more than $1.84 million in National Health and Medical Research Council (NHMRC) funding.

12

Dec

Mater Research awarded $1.84 million in NHMRC funding

Mater Group is proud to mark a milestone in its history, the launch of a new brand, to reposition Mater as a group incorporating health, education and research for a healthy community.

21

Nov

We’re Mater, and we’re better together

A Mater researcher has developed a method to predict breast cancer patient responses to a commonly prescribed breast cancer drug.

14

Nov

New test predicts breast cancer patients at risk of relapse

A new mobile phone app being trialled at Mater Mothers’ Hospital Brisbane aims to reduce the rate of stillbirth in Australia by 30 per cent by focusing on a baby’s kicks.

31

Oct

App hopes to reduce stillbirths by 30 per cent

A new triple-combination drug trialled at Mater in Brisbane could increase the life expectancy of patients with cystic fibrosis (CF).

19

Oct

Mater helps bring new hope to patients with cystic fibrosis

Mater Research is planning the largest group cohort study in the state since the 1980s, aiming to follow 10 000 Queensland families over three decades, in collaboration with Queensland universities...

09

Aug

Mater Research planning for largest cohort study in Queensland

Displaying results 121-132 (of 139)
 |<  <  3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 - 12  >  >|